IE44603B1 - 2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives - Google Patents
2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivativesInfo
- Publication number
- IE44603B1 IE44603B1 IE297/77A IE29777A IE44603B1 IE 44603 B1 IE44603 B1 IE 44603B1 IE 297/77 A IE297/77 A IE 297/77A IE 29777 A IE29777 A IE 29777A IE 44603 B1 IE44603 B1 IE 44603B1
- Authority
- IE
- Ireland
- Prior art keywords
- mixture
- group
- compound
- oxo
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65778776A | 1976-02-13 | 1976-02-13 | |
US05/748,851 US4082751A (en) | 1976-02-13 | 1976-12-08 | Therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
IE44603L IE44603L (en) | 1977-08-13 |
IE44603B1 true IE44603B1 (en) | 1982-01-27 |
Family
ID=27097492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE297/77A IE44603B1 (en) | 1976-02-13 | 1977-02-11 | 2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS52118481A (da) |
AU (1) | AU508970B2 (da) |
CA (1) | CA1083152A (da) |
CH (1) | CH635339A5 (da) |
DE (1) | DE2705609A1 (da) |
DK (1) | DK149044C (da) |
FI (1) | FI62533C (da) |
FR (1) | FR2340943A1 (da) |
GB (1) | GB1541351A (da) |
IE (1) | IE44603B1 (da) |
LU (1) | LU76722A1 (da) |
NL (1) | NL173055C (da) |
SE (1) | SE433494B (da) |
YU (1) | YU41567B (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4419357A (en) * | 1982-01-18 | 1983-12-06 | The Dow Chemical Company | 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones |
CN101747282A (zh) * | 2008-12-10 | 2010-06-23 | 上海特化医药科技有限公司 | 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3883653A (en) * | 1972-10-24 | 1975-05-13 | Pfizer | Method of preventing asthmatic symptoms |
-
1977
- 1977-02-03 AU AU21895/77A patent/AU508970B2/en not_active Expired
- 1977-02-08 LU LU76722A patent/LU76722A1/xx unknown
- 1977-02-09 FR FR7703650A patent/FR2340943A1/fr active Granted
- 1977-02-09 FI FI770427A patent/FI62533C/fi not_active IP Right Cessation
- 1977-02-09 CA CA271,406A patent/CA1083152A/en not_active Expired
- 1977-02-09 GB GB5437/77A patent/GB1541351A/en not_active Expired
- 1977-02-10 DE DE19772705609 patent/DE2705609A1/de active Granted
- 1977-02-10 DK DK57377A patent/DK149044C/da not_active IP Right Cessation
- 1977-02-11 SE SE7701552A patent/SE433494B/xx not_active IP Right Cessation
- 1977-02-11 CH CH173477A patent/CH635339A5/de not_active IP Right Cessation
- 1977-02-11 YU YU354/77A patent/YU41567B/xx unknown
- 1977-02-11 NL NLAANVRAGE7701483,A patent/NL173055C/xx not_active IP Right Cessation
- 1977-02-11 IE IE297/77A patent/IE44603B1/en unknown
- 1977-02-14 JP JP1433577A patent/JPS52118481A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS52118481A (en) | 1977-10-04 |
FI62533C (fi) | 1983-01-10 |
FR2340943A1 (fr) | 1977-09-09 |
NL173055C (nl) | 1983-12-01 |
DE2705609A1 (de) | 1977-08-25 |
FI62533B (fi) | 1982-09-30 |
AU508970B2 (en) | 1980-04-17 |
FI770427A (da) | 1977-08-14 |
YU35477A (en) | 1982-10-31 |
AU2189577A (en) | 1978-08-10 |
YU41567B (en) | 1987-10-31 |
DE2705609C2 (da) | 1988-12-15 |
LU76722A1 (da) | 1977-08-18 |
DK57377A (da) | 1977-08-14 |
FR2340943B1 (da) | 1981-01-09 |
NL7701483A (nl) | 1977-08-16 |
DK149044B (da) | 1985-12-30 |
CA1083152A (en) | 1980-08-05 |
IE44603L (en) | 1977-08-13 |
NL173055B (nl) | 1983-07-01 |
SE7701552L (sv) | 1977-09-23 |
JPS6139947B2 (da) | 1986-09-06 |
SE433494B (sv) | 1984-05-28 |
GB1541351A (en) | 1979-02-28 |
DK149044C (da) | 1986-06-02 |
CH635339A5 (en) | 1983-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1098520A (en) | Optionally substituted 3-(1h-tetrazol-5-yl)-4h- pyrido¬1,2-a| pyrimidin-4-ones | |
US3883653A (en) | Method of preventing asthmatic symptoms | |
CA1315287C (en) | Substituted bis-(4-aminophenyl)-sulfones, their preparation and their use as pharmaceutical compositions | |
JPH09301958A (ja) | 新規ピリミジン化合物及び抗ロタウイルス剤 | |
FI61688B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara oxminsyraderivat | |
US4082751A (en) | Therapeutic agents | |
US4031093A (en) | 1,6-Dihydro-6-oxo-2-(ortho-substituted phenyl)pyrimidine-5-carboxylic acid derivatives | |
IE44603B1 (en) | 2-phenyl-5-(5-tetrazolyl)-pyrimidin-4(3h)-one derivatives | |
EP0244201B1 (en) | 3-hydroxypyridines | |
JPS6160072B2 (da) | ||
CA1117112A (en) | Pyrido¬1,2-a|pyrimidine-3-n-(1h-tetrazol-5-yl| carboxamide derivatives | |
US3927214A (en) | Method of preventing asthmatic symptoms | |
US3957784A (en) | Bis(4-[4'-hydroxy-5'-carboxy-2'-pyrimidinyl]phenoxy)alkanes | |
US3968213A (en) | Method of preventing asthmatic symptoms | |
US4096153A (en) | Arylene-bis-tetrazole-5-carboxamides | |
EP0064385B1 (en) | 2,6-diaryl-pyridinecarboxylic acids and their therapeutic utility | |
SU1342410A3 (ru) | Способ получени диазинсодержащих производных оксаминовой кислоты или их солей с первичными или вторичными аминами,или щелочными металлами,или кислотно-аддитивных солей с минеральными кислотами | |
US3927215A (en) | Method of preventing asthmatic symptoms | |
US3974161A (en) | Fused pyrimidin-4(3H)-ones as antiallergy agents | |
EP0050977B1 (en) | Carboxamide compounds as srs-a antagonists and a process for producing same | |
US3917835A (en) | A method of preventing asthmatic symptoms | |
US4254126A (en) | 4-Carbethoxy-carbonilamino-pyrimidines and a process for their preparation | |
US4330555A (en) | Indanyloxamic derivatives, their preparation and pharmaceutical compositions containing them | |
KR800001139B1 (ko) | N-(5-테트라졸릴)-4-옥소-4H-피리미도[2,1-b]벤조티아졸류의 제조방법 | |
JPS6238356B2 (da) |